NHERF1 was further demonstrated to retard cell proliferation with the attenuation of Wnt/β-catenin pathway activation of cervical cancer cells in vivo and in vitro through suppression of α-actinin-4 (ACTN4) expression level. This evidence concerns the gene ACTN4 and cervical cancer.